Quarterly report · Q3

Period2023-06-01 → 2024-02-29
Filed2024-04-12
StandardJapan GAAP
ConsolidatedNo
Data checks10 of 10 passed
Key figures · 38
MetricValuePeriodScopeSource row
Revenue¥4.5bn2023-06-01 → 2024-02-29StandaloneNet sales
Revenue¥6.3bn2022-06-01 → 2023-05-31StandaloneNet sales (5-year summary)
Revenue¥4.6bn2022-06-01 → 2023-02-28StandaloneNet sales
Operating income¥252m2023-06-01 → 2024-02-29StandaloneOperating income
Operating income¥325m2022-06-01 → 2023-02-28StandaloneOperating income
Ordinary income¥246m2023-06-01 → 2024-02-29StandaloneOrdinary income
Ordinary income¥351m2022-06-01 → 2023-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥309m2022-06-01 → 2023-02-28StandaloneOrdinary income
Profit before tax¥287m2023-06-01 → 2024-02-29StandaloneIncome before income taxes
Profit before tax¥309m2022-06-01 → 2023-02-28StandaloneIncome before income taxes
Net income¥191m2023-06-01 → 2024-02-29StandaloneProfit loss
Net income¥256m2022-06-01 → 2023-05-31StandaloneNet income loss (5-year summary)
Net income¥230m2022-06-01 → 2023-02-28StandaloneProfit loss
Total assets¥5.3bnat 2024-02-29StandaloneAssets
Total assets¥4.9bnat 2023-05-31StandaloneAssets
Total assets¥5.0bnat 2023-02-28StandaloneTotal assets (5-year summary)
Total liabilities¥3.2bnat 2024-02-29StandaloneLiabilities
Total liabilities¥3.0bnat 2023-05-31StandaloneLiabilities
Net assets / equity¥2.1bnat 2024-02-29StandaloneNet assets
Net assets / equity¥1.9bnat 2023-05-31StandaloneNet assets
Net assets / equity¥1.9bnat 2023-02-28StandaloneNet assets (5-year summary)
Cash and deposits¥954mat 2024-02-29StandaloneCash and deposits
Cash and deposits¥853mat 2023-05-31StandaloneCash and deposits
EPS (basic)¥48.22023-06-01 → 2024-02-29StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥24.522023-12-01 → 2024-02-29dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥61.462022-06-01 → 2023-02-28StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥21.532022-12-01 → 2023-02-28dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥47.272023-06-01 → 2024-02-29StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.122022-06-01 → 2023-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥58.552022-06-01 → 2023-02-28StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192022-06-01 → 2023-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio39.9%at 2024-02-29StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio37.5%at 2023-02-28StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2024-02-29StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-02-28StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥1.6bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥1.6bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2024-02-29−¥22m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥563m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥563m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2024-02-29−¥40m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2024-02-29¥2.3bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2024-02-29¥2.3bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2024-02-29¥314m
—segment totalrevenue2023-06-01 → 2024-02-29¥4.5bn
—segment totalrevenue external2023-06-01 → 2024-02-29¥4.5bn
—segment totalsegment profit2023-06-01 → 2024-02-29¥252m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2024-02-29¥4.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2024-02-29¥4.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2024-02-29¥252m
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥1.5bn
jpcrp040300-q3r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥25m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥528m
jpcrp040300-q3r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2023-02-28−¥75m
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2023-02-28¥2.6bn
jpcrp040300-q3r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2023-02-28¥426m
—segment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
—segment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
—segment totalsegment profit2022-06-01 → 2023-02-28¥325m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2023-02-28¥4.6bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2023-02-28¥325m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 369
ItemContextValueUnit
Deposit for subscriptions to treasury stockCurrentQuarterInstant_NonConsolidatedMember-JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember1896740000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember2030158000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember18488000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember65447000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember18488000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember65447000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1915229000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember2095606000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember4948311000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember5250574000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember4624606000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember4455013000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember3300480000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember3150154000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember1324125000JPY
Gross profitCurrentYTDDuration_NonConsolidatedMember1304858000JPY
Salaries and allowances sgaPrior1YTDDuration_NonConsolidatedMember336774000JPY
Salaries and allowances sgaCurrentYTDDuration_NonConsolidatedMember355227000JPY
Legal welfare expenses sgaPrior1YTDDuration_NonConsolidatedMember77904000JPY
Legal welfare expenses sgaCurrentYTDDuration_NonConsolidatedMember79780000JPY
Provision for bonuses sgaPrior1YTDDuration_NonConsolidatedMember79069000JPY
Provision for bonuses sgaCurrentYTDDuration_NonConsolidatedMember79971000JPY
Retirement benefit expenses sgaPrior1YTDDuration_NonConsolidatedMember11542000JPY
Retirement benefit expenses sgaCurrentYTDDuration_NonConsolidatedMember14839000JPY
Share based compensation expenses sgaPrior1YTDDuration_NonConsolidatedMember7761000JPY
Share based compensation expenses sgaCurrentYTDDuration_NonConsolidatedMember4506000JPY
Other sgaPrior1YTDDuration_NonConsolidatedMember485664000JPY
Other sgaCurrentYTDDuration_NonConsolidatedMember518143000JPY
Selling general and administrative expensesPrior1YTDDuration_NonConsolidatedMember998715000JPY
Selling general and administrative expensesCurrentYTDDuration_NonConsolidatedMember1052469000JPY
Operating incomePrior1YTDDuration_NonConsolidatedMember325409000JPY
Operating incomeCurrentYTDDuration_NonConsolidatedMember252388000JPY
Interest income noiPrior1YTDDuration_NonConsolidatedMember27000JPY
Interest income noiCurrentYTDDuration_NonConsolidatedMember1798000JPY
Dividends income noiPrior1YTDDuration_NonConsolidatedMember781000JPY
Dividends income noiCurrentYTDDuration_NonConsolidatedMember1996000JPY
Foreign exchange gains noiPrior1YTDDuration_NonConsolidatedMember-JPY
Foreign exchange gains noiCurrentYTDDuration_NonConsolidatedMember1150000JPY
Subsidy income noiPrior1YTDDuration_NonConsolidatedMember851000JPY
Subsidy income noiCurrentYTDDuration_NonConsolidatedMember-JPY
Insurance fee income noiPrior1YTDDuration_NonConsolidatedMember5405000JPY
Insurance fee income noiCurrentYTDDuration_NonConsolidatedMember1497000JPY
Other noiPrior1YTDDuration_NonConsolidatedMember2481000JPY
Other noiCurrentYTDDuration_NonConsolidatedMember1615000JPY
Non operating incomePrior1YTDDuration_NonConsolidatedMember9546000JPY
Non operating incomeCurrentYTDDuration_NonConsolidatedMember8057000JPY
Interest expenses noePrior1YTDDuration_NonConsolidatedMember12891000JPY
Interest expenses noeCurrentYTDDuration_NonConsolidatedMember13336000JPY
Foreign exchange losses noePrior1YTDDuration_NonConsolidatedMember12662000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 10 of 10 passed
balance sheet identitynon_consolidated 2023-05-31pass
balance sheet identitynon_consolidated 2024-02-29pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2024-02-29pass
statement vs summary · revenuenon_consolidated 2022-06-01/2023-02-28pass
statement vs summary · revenuenon_consolidated 2023-06-01/2024-02-29pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2024-02-29pass